Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
780.60
Change Change %
-2.50 -0.32%

Updated:15 Nov, 2018, 15:59 PM IST

BSE
780.20
Change Change %
-2.50 -0.32%

Updated:15 Nov, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
04-04-2016 Buy 730.60 1050.00
N/A
Closed Long (1Y)
04-04-2017

Citi maintains buy on Aurobindo Pharma

Citi has maintained buy on Aurobindo Pharma for target of Rs 1,050/share. It says Aurobindo started FY17 in same way as FY16 and full upside in earnings will come in next few quarters. Citi expects earnings growth to remain robust and street underestimates rising relevance of Aurobindo.

Top